Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nuvectis Pharma Inc (NVCT)

Nuvectis Pharma Inc (NVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nuvectis Pharma Inc 1 BRIDGE PLAZA SUITE 275 FORT LEE NJ 07024 USA

www.nuvectis.com Employees: 13 P: 201-614-3150

Sector:

Medical

Description:

Nuvectis Pharma Inc. is a biopharmaceutical company. It focused on the development of innovative precision medicines for serious conditions of unmet medical need in oncology. Nuvectis Pharma Inc. is based in Fort Lee, NJ.

Key Statistics

Overview:

Market Capitalization, $K 217,215
Enterprise Value, $K 198,685
Shares Outstanding, K 25,615
Float, K 17,797
% Float 69.48%
Short Interest, K 1,533
Short Float 5.98%
Days to Cover 19.61
Short Volume Ratio 0.55
% of Insider Shareholders 30.52%
% of Institutional Shareholders 96.77%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -19,000 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,460 K
EBIT, $ -26,410 K
EBITDA, $ -26,410 K

Growth:

1-Year Return 50.46%
3-Year Return 13.07%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.44 on 11/04/25
Next Earnings Date 02/24/26
Earnings Per Share ttm -1.37
EPS Growth vs. Prev Qtr -46.67%
EPS Growth vs. Prev Year -83.33%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

NVCT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -155.45%
Return-on-Assets % -99.88%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 8.99
Book Value/Share 0.94
Interest Coverage -1.74
60-Month Beta -0.30
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar